CLPTM1L Polyclonal Antibody
SKU: E-AB-16347-200
CLPTM1L Polyclonal Antibody
| SKU # | E-AB-16347 |
| Reactivity | Human |
| Host | Rabbit |
| Applications | IHC |
Product Details
| Isotype | IgG |
| Host | Rabbit |
| Reactivity | Human |
| Applications | IHC |
| Clonality | Polyclonal |
| Immunogen | Synthetic peptide of human CLPTM1L |
| Abbre | CLPTM1L |
| Synonyms | C130052I12Rik, CLP1, Cisplatin resistance related protein 9, Cisplatin resistance related protein CRR9p, Cisplatin resistance-related protein 9, Cleft lip and palate transmembrane protein 1 like protein, Cleft lip and palate transmembrane protein 1-like protein |
| Swissprot | |
| Cellular Localization | Membrane. |
| Concentration | 0.7 mg/mL |
| Buffer | Phosphate buffered solution, pH 7.4, containing 0.05% stabilizer and 50% glycerol. |
| Purification Method | Affinity purification |
| Research Areas | Cell biology |
| Conjugation | Unconjugated |
| Storage | Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles. |
| Shipping | The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended. |
Related Reagents
| Applications | Recommended Dilution |
| IHC | 1:50-1:200 |
Background
Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein), also known as cisplatin resistance-related protein 9 (CRR9p), is a protein that in humans is encoded by the CLPTM1L gene.CRR9p is associated with cisplatin-induced apoptosis.CLPTM1L, which lies within a cancer susceptibility locus on chromosome 5 (5p15.33), has been found to be commonly over-expressed in lung tumors and to confer resistance to apoptosis caused by genotoxic agents in association with up-regulation of the anti-apoptotic protein, Bcl-xL.